Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.50 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28992535 | 0.89 | HCRTR1 (0.62) | HCRTR1L3MBTL1GLAMAPTGAA | |
| SCHEMBL6464181 | 0.89 | HCRTR1 (0.62) | HCRTR1L3MBTL1GLAMAPTGAA | |
| SCHEMBL536025 | 0.87 | TSHR (0.71) | HCRTR1L3MBTL1GLAMAPTGAA | |
| SCHEMBL30553984 | 0.87 | HCRTR1 (0.65) | HCRTR1L3MBTL1MAPTGAAMAPK1 | |
| SCHEMBL1989129 | 0.87 | HCRTR1 (0.65) | HCRTR1L3MBTL1MAPTGAAMAPK1 | |
| SCHEMBL24074018 | 0.85 | HCRTR1 (0.58) | HCRTR1L3MBTL1GLAMAPTGAA | |
| SCHEMBL1006864 | 0.85 | HCRTR1 (0.58) | HCRTR1L3MBTL1GLAMAPTGAA | |
| SCHEMBL29196402 | 0.85 | LMNA (0.59) | L3MBTL1MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL7945834 | 0.85 | HCRTR1 (0.58) | HCRTR1L3MBTL1GLAMAPTGAA | |
| SCHEMBL7057320 | 0.85 | HCRTR1 (0.58) | HCRTR1L3MBTL1GLAMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111194206-A | Composition containing benzoic acid derivatives or furoic acid derivatives and use of the derivatives for emulsion and foam stability | 西姆莱斯股份公司 | 2020-05-22 | — | — | CN | claimed |
| US-6951904-B1 | Process for increasing the melt strength of polypropylene | POLYMERS AUSTRALIA PTY LIMITED (AU) | 2005-10-04 | — | — | US | claimed |
| EP-1287043-A4 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | SAMSUNG GENERAL CHEMICALS CO (KR) | 2004-08-25 | — | — | EP | claimed |
| EP-1287043-A1 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | Samsung General Chemicals Co., Ltd. (KR) | 2003-03-05 | — | — | EP | claimed |
| EP-1080148-A4 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | POLYMERS AUSTRALIA PTY LTD (AU) | 2003-02-05 | — | — | EP | claimed |
| WO-2001092345-A1 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-12-06 | — | — | WO | claimed |
| EP-1080148-A1 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | Polymers Australia PTY Limited (AU) | 2001-03-07 | — | — | EP | claimed |
| WO-1999036466-A1 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | POLYMERS AUSTRALIA PTY LIMITED (AU) | 1999-07-22 | — | — | WO | claimed |
| US-20260108497-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICALC., LTD. (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-20220265613-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-08-25 | — | — | US | disclosed |
| US-20200078340-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-03-12 | — | — | US | disclosed |
| US-20190070151-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-03-07 | — | — | US | disclosed |
| US-RE46792-E1 | Oxazole compound and pharmaceutical composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| WO-2007058338-A9 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMA CO LTD (JP) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007058338-A2 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-05-24 | — | — | WO | disclosed |
| US-6951904-B1 | Process for increasing the melt strength of polypropylene | POLYMERS AUSTRALIA PTY LIMITED (AU) | 2005-10-04 | — | — | US | disclosed |
| EP-1080148-A4 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | POLYMERS AUSTRALIA PTY LTD (AU) | 2003-02-05 | — | — | EP | disclosed |
| EP-1080148-A1 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | Polymers Australia PTY Limited (AU) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999036466-A1 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | POLYMERS AUSTRALIA PTY LIMITED (AU) | 1999-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | HCRTR1 1318/4885L3MBTL1 4602/4885GLA 1627/4885 |
| US-20260108497-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE7B, PDE4B, PDE1B | HCRTR1 3861/4885L3MBTL1 4619/4885GLA 2368/4885 |
| US-20200078340-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | HCRTR1 1318/4885L3MBTL1 4602/4885GLA 1627/4885 |
| US-20220265613-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | HCRTR1 1254/4885L3MBTL1 4706/4885GLA 2019/4885 |
| US-20190070151-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | HCRTR1 1318/4885L3MBTL1 4602/4885GLA 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.